Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
bone marrow-derived mesenchymal stem cell
- Development stage
- Phase 1
- Lead developer
- Mesoblast
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intraarticular, Intramuscular, Intrathecal, Intracoronary, Intramyocardial, Intraosseous, Intradiscal
01
Overview
Bone marrow-derived mesenchymal stem cells (BM-MSCs) are multipotent adult stem cells isolated from the stromal compartment of bone marrow. They have the capacity for self-renewal and can differentiate into various mesodermal lineages including osteoblasts (bone), chondrocytes (cartilage), myocytes (muscle), and adipocytes (fat)[1][3][4]. BM-MSCs exhibit immunomodulatory properties, secrete trophic factors that promote tissue repair, and modulate inflammatory responses. These features make them promising candidates for regenerative medicine and cellular therapies in a range of degenerative, inflammatory, autoimmune diseases as well as tissue engineering[2][4]. Clinical trials have explored their use in conditions such as graft-versus-host disease (GvHD), cardiovascular diseases, neurological disorders, COVID-19 ARDS, Crohn’s disease, pulmonary fibrosis and more[6][8][9].
- Other names
- bone marrow-derived mesenchymal stromal cellBM-MSCbone marrow MSCbone marrow mesenchymal stem cell
Beyond the preview
Go deeper on bone marrow-derived mesenchymal stem cell.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on bone marrow-derived mesenchymal stem cell.